Pilot Study on the Adaptation and Tolerance of Essilor® Myopia-control Spectacle Lenses
ConditionMyopia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-16
SponsorNantes University Hospital
About this trial
This observational pilot study aims to evaluate the adaptation and tolerance of Essilor® Stellest® myopia-control spectacle lenses in children with progressive myopia. The objective is to assess real-life compliance and comfort during lens wear, as these factors are essential for long-term therapeutic adherence and overall visual health outcomes
Eligibility criteria
Qualifiers
Patients aged 6 to 16 years with progressive myopia.
Spherical equivalent ≤ -0.50 D under cycloplegia and presence of at least one risk factor (age < 10 years, progression ≥ 0.50 D/year, axial length increase ≥ 0.2 mm/year, high myopia ≤ -6.00 D and/or axial length ≥ 26 mm, both parents myopic, at least one parent highly myopic, or Asian origin).
Patient covered by the French social security system.
Patient and legal guardians providing oral non-opposition to participate in the study.
Disqualifiers
Patients with strabismus, amblyopia, or syndromic myopia
Trial design
Treatments tested in this trial
- Not listed
Trial groups
50 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov